During the past decade, Gemini One conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gemini One" are "Breast Cancer" (1 trials), "Breast Diseases" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Gemini One" in a lesser frequency.

Most popular intervention types in "Gemini One" are "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Multiparametric MRI" (1 trials) and "Outpatient MRI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gemini One" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Gemini One". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Gemini One, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gemini One, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".